How much funding has VBI Vaccines raised?

VBI Vaccines has raised $35.7M in total funding, most recently a Series A round.

Who are VBI Vaccines's investors?

VBI Vaccines's investors include Paulson & Co., 5AM Ventures.

Where is VBI Vaccines headquartered?

VBI Vaccines is headquartered in Cambridge, United States.

What industry is VBI Vaccines in?

VBI Vaccines operates in Biotech, Healthcare.

How many employees does VBI Vaccines have?

VBI Vaccines has 51-200 employees.

VBI Vaccines

Closed

Activating the Power Within

Cambridge, United States · $35.7M raised

Biotech

Healthcare

Headquarters: Cambridge
Employees: 51–200
Business Model: B2B
Website: vbivaccines.com

Total Funding: $35.7M
Last Round: $35.7M Series AJan 2007
Rounds: 1

About

VBI Vaccines Inc. (Nasdaq: VBIV) was a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, developing vaccine and immunotherapeutic candidates based on virus-like particle technology designed to closely mimic the natural presentation of viruses and elicit a potent immune response. Its pipeline targeted major unmet medical needs, including cytomegalovirus and other infectious diseases, as well as aggressive cancers such as glioblastoma. In 2024 the company initiated restructuring proceedings under Canada's CCAA and issued a voluntary nationwide recall of its PreHevbrio hepatitis B vaccine following the discontinuation of company operations.

Summary

VBI Vaccines is a Biotech company based in Cambridge, United States. It has raised $35.7M in total across 1 round, most recently a $35.7M Series A round in Jan 2007. Investors include Paulson & Co. and 5AM Ventures.